Bortezomib 3.5mg Injection – Latest Update for Global Supply
Cordium Pharmaceuticals Pvt Ltd, a trusted global exporter based in India, offers high-quality Bortezomib 3.5mg Injection with fast and reliable delivery to countries including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. Our commitment to quality, compliance, and timely shipping makes us a preferred partner in oncology pharmaceutical exports.
What is Bortezomib 3.5mg Injection?
Bortezomib is a proteasome inhibitor widely used in the treatment of certain types of cancer, particularly:
Multiple Myeloma
Mantle Cell Lymphoma
It works by blocking proteasome activity in cancer cells, leading to cell death and slowing disease progression.
Usage of Bortezomib Injection
Bortezomib is administered under medical supervision and is typically used:
As a first-line or relapsed therapy for multiple myeloma
In combination with other chemotherapy agents
For patients with mantle cell lymphoma who have received prior treatment
Dosage Information
Standard dosage: 1.3 mg/m² body surface area
Administered via intravenous (IV) or subcutaneous (SC) injection
Given twice weekly for 2 weeks, followed by a 10-day rest period (21-day cycle)
Dosage adjustments may be required based on patient condition and tolerance
Note: Always follow the oncologist’s prescription and guidelines.
Possible Side Effects
Common side effects may include:
Fatigue and weakness
Nausea and vomiting
Peripheral neuropathy (tingling or numbness in hands/feet)
Low platelet count (thrombocytopenia)
Diarrhea or constipation
Fever and infection risk
Serious side effects should be reported to a healthcare provider immediately.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global exporter from India
Assured quality & regulatory compliance
Competitive pricing for bulk orders
Fast delivery worldwide
Reliable customer support
Contact Us for Orders & Enquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
